Jonušaitė, I., N. Giedraitienė, G. Kaubrys, and R. Kizlaitienė. “The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab”. Neurologijos seminarai 27, no. 3 (97) (March 20, 2024): 127–135. Accessed April 27, 2025. https://journals.vu.lt./neurologijos_seminarai/article/view/34911.